TRYPANOSOMIASIS

TRYPANOSOMIASIS was reported 2 times

TRYPANOSOMIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
1 Topoisomerase Inhibitor [EPC] 1 0.0000
2 Alkylating Drug [EPC] 1 0.0000
3 Platinum-based Drug [EPC] 1 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
6 Thalidomide Analog [EPC] 1 0.0000
7 Corticosteroid [EPC] 1 0.0000